Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $602.03 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $148.78 | 2 | $0 (2022) |
| Genentech USA, Inc. | $133.45 | 1 | $0 (2019) |
| Exelixis Inc. | $96.76 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $82.68 | 1 | $0 (2023) |
| Amgen Inc. | $41.83 | 2 | $0 (2023) |
| SOBI, INC | $32.16 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $31.33 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $20.47 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.57 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.96 | 3 | SOBI, INC ($32.16) |
| 2023 | $124.51 | 3 | AstraZeneca Pharmaceuticals LP ($82.68) |
| 2022 | $23.78 | 1 | ABBVIE INC. ($23.78) |
| 2021 | $139.57 | 2 | AbbVie Inc. ($125.00) |
| 2020 | $96.76 | 1 | Exelixis Inc. ($96.76) |
| 2019 | $133.45 | 1 | Genentech USA, Inc. ($133.45) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Immunology | ||||||
| 03/07/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Oncology | ||||||
| 09/06/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $82.68 | General |
| 07/24/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Oncology | ||||||
| 12/15/2022 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/25/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/26/2020 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $96.76 | General |
| Category: Oncology | ||||||
| 04/16/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $133.45 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 203 | 818 | $329,983 | $84,949 |
| 2022 | 5 | 113 | 358 | $79,634 | $24,975 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 62 | 383 | $166,287 | $38,204 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 34 | 263 | $99,940 | $31,340 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 81 | $23,384 | $5,374 | 23.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 21 | $13,290 | $3,053 | 23.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 29 | 30 | $12,628 | $2,872 | 22.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $7,798 | $2,124 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 26 | $6,656 | $1,981 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 113 | $28,928 | $9,461 | 32.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 114 | $22,002 | $6,830 | 31.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 68 | $18,428 | $5,841 | 31.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 49 | $6,076 | $1,597 | 26.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $4,200 | $1,246 | 29.7% |
About Amanda Blackmon
Amanda Blackmon is a Hematology healthcare provider based in Duarte, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2015. The National Provider Identifier (NPI) number assigned to this provider is 1841685997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Blackmon has received a total of $602.03 in payments from pharmaceutical and medical device companies, with $83.96 received in 2024. These payments were reported across 11 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($602.03).
As a Medicare-enrolled provider, Blackmon has provided services to 316 Medicare beneficiaries, totaling 1,176 services with total Medicare billing of $109,924. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Location Duarte, CA
- Active Since 04/04/2015
- Last Updated 05/06/2021
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1841685997
Products in Payments
- TECENTRIQ (Biological) $133.45
- Cabometyx (Drug) $96.76
- Blincyto (Biological) $41.83
- DOPTELET (Drug) $32.16
- Fabhalta (Drug) $31.33
- VENCLEXTA (Drug) $23.78
- KEYTRUDA (Biological) $20.47
- LIVTENCITY (Drug) $14.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Duarte
Mr. Vinod Pullarkat, M.d, M.D
Hematology — Payments: $639,378
Guido Marcucci, M.d, M.D
Hematology — Payments: $176,185
Alex Herrera, Md, MD
Hematology — Payments: $165,071
Dr. Joseph Chao, M.d, M.D
Hematology — Payments: $152,551
John Baird, Md, MD
Hematology — Payments: $48,735
Dr. Idoroenyi Amanam, M.d, M.D
Hematology — Payments: $22,530